MAESTRO-WIRELESS/FALCOM
6.6.2014 09:02:00 CEST | Business Wire | Pressemeddelelse
Maestro Wireless Solutions Limited (“Maestro”) , a global provider of machine-to-machine (“M2M”) and Internet of Things (“IoT”) solutions, today finalised the acquisition of the assets of Falcom Wireless Communications GmbH, a renowned provider of tracking solutions. The said assets are being injected into the newly established FALCOM GmbH (“FALCOM”) , of which Maestro detains a majority stake whereas its management, consisting of Messrs Holger Liebold , Stephan Orlamünder , Guido Voigt and Rudy Alix , holds the balance.
Said Holger Liebold , managing director of FALCOM: “We are very pleased to emerge with all our forces intact from a challenging chapter of our 23-year history: indeed, the insolvency of our previous parent company has caused our clients, suppliers and obviously ourselves some complications and we are very keen now on restoring FALCOM to its former glory with the full support of Maestro, be it financial, marketing or geographical, Maestro being already present in six other countries over three continents.”
Xavier Dupont , chief executive officer of Fargo Telecom Holdings Limited, of which Maestro is a fully-owned subsidiary, added: “We are extremely pleased to add FALCOM to our growing stable of IoT companies; beyond its sizeable business, its comprehensive portfolio of beautifully crafted products and services, its substantial footprint in the heart of Europe and, last but not least, its seasoned management, FALCOM also brings us a world-class R&D team with unparalleled experience in telematics and an historic, powerful, brand; the synergies between the parties are truly striking and we look forward to a bright future together.”
About FALCOM
A storied M2M specialist from Germany, FALCOM now designs, manufactures and sells world-wide state-of-the-art trackers. Their value, enhanced further by innovative software offerings, helped establish FALCOM as a leading provider of end-to-end tracking and telematics solutions.
About Maestro Wireless Solutions
Maestro Wireless Solutions, an M2M and IoT specialist, is a fully-owned subsidiary of Fargo Telecom Holdings, itself a majority-owned subsidiary of Hong Kong publicly listed Telefield International (Holdings). With a local presence in China, Thailand, India, France, Brazil and the USA, Maestro has a global reach through its comprehensive network of distributors and partners; so far, over 400,000 Maestro modems have been deployed in more than forty countries.
http://www.maestro-wireless.com/
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140606005131/en/
Contact:
Maestro Wireless Solutions
Matthieu Boulanger, +852 9863 5154
matthieu.boulanger@maestro-wireless.com
or
FALCOM
Holger
Liebold, +49 3677 8042 0
holger.liebold@falcom.de
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
DCX builds coolant chemistry control into its 8 MW Facility Distribution Unit19.10.2026 14:01:00 CEST | Press release
DCX introduces groundbreaking new safety standard protecting critical AI infrastructure by monitoring and keeping the entire coolant loop Continuous monitoring of eight coolant parameters and automatic dosing keep hall-scale liquid-cooling loops in specification between service visits Today DCX Liquid Cooling Systems announced worldwide’s first CDU system with built-in coolant control and treatment system. DCX integrated this coolant quality feature into it’s Facility Coolant Distribution Units: a family of 5-8 MW capable hyperscale-class coolant Distribution Units. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014488003/en/ DCX announces the world’s first CDU with built-in coolant quality control and treatment - a new safety standard for hall-scale Liquid Cooling in critical AI infrastructure. The FDU monitors the chemistry of its coolant continuously and corrects it automatically with integrated electronic dosing pumps
STARTEEPO Sends Letter to Xerox Board in Advance of Third-Quarter Earnings19.10.2026 14:00:00 CEST | Press release
Company’s Third Largest Shareholder Expects Update on Increased Transparency, Strategic Review of Xerox Financial Services Business Unit, and Continued DeleveragingSTARTEEPO Chairman František Bostl to Address Xerox Investment at Skytop Conference in London STARTEEPO SICAV a.s. (“STARTEEPO”), which beneficially owns 7.34% of Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQ: XRX) in stocks and options, today issued the following letter to the Xerox Board of Directors (the “Board”): October 19, 2026 The Board of Directors Xerox Holdings Corp. 401 Merritt 7 Norwalk, CT 06851 Dear Members of the Board: Our open letter to the Board in early September helped spark a lively conversation about the future of this iconic company among investors and throughout the print industry. Despite these efforts, Xerox’s share price still does not reflect the significant value we see in the Company, a gap recently confirmed by Citi’s downgrade of Xerox stock to reflect the challenge of executin
The Data Center Marketplace Is Booming, Inaugural Data Center World Europe Unites Data Center and Energy Decision-Makers and Expertsin Vienna19.10.2026 12:00:00 CEST | Press release
Data Center World Europe 2027 took place October 13-15 at VIECON – Vienna Congress & Convention Center in Austria Last week, Data Center World Europe, where data centre developers, AI and cloud providers, energy and utility operators, and solution providers come together to drive the development of an AI-ready, sustainable future, united leading operators, technologists, cloud providers, hyperscalers and energy management innovators over three days at VIECON – Vienna Congress & Convention Center in Vienna, Austria. It was co-located with the leading global network infrastructure event Network X, where data centre developers, AI and cloud providers, energy and utility operators, and solution providers come together to drive the development of an AI-ready, sustainable future, united leading operators, technologists, cloud providers, hyperscalers and energy management innovators. Tara Gibb, Senior Director, Data Center World Europe said, “The conference tackled the industry’s most urgent
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 202619.10.2026 12:00:00 CEST | Press release
New data from four priority programs, including the GPC3x4-1BB bispecific antibody, CEA targeting ADC, CDK4 inhibitor, and brain-penetrant PRMT5 inhibitor underscore the depth of BeOne’s solid tumor pipelineMultiple TEVIMBRA abstracts reinforce breadth of evidence across lung and gastrointestinal cancers, including data in combination with ZIIHERA in HER2+ gastroesophageal cancer BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from across its rapidly progressing solid tumor portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress 2026 on October 23-27 in Madrid. Presentations will highlight an accelerating pipeline of differentiated targeted therapies, alongside a broad body of evidence for TEVIMBRA® (tislelizumab), including a late-breaking rapid oral presentation on TEVIMBRA in combination with ZIIHERA® (zanidatamab) in HER2+ gastroesophageal adenocarcinoma (GEA). Priority pipeline data
First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication19.10.2026 11:30:00 CEST | Press release
More than half of ENTYVIO patients who met their assigned treatment target reached disease clearance (composite of corticosteroid-free symptomatic, endoscopic and histologic remission) at Week 16VERDICT is the first trial to provide macroscopic and microscopic evidence of intestinal tissue repair associated with disease clearance in largely bio-naïve patients treated with an advanced therapy Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ENTYVIO® (vedolizumab) to achieve corticosteroid-free (CSF) disease clearance versus CSF symptomatic remission alone, resulted in a significantly longer time to first ulcerative colitis (UC)-related complication (hazard ratio 0.33 [95% confidence interval 0.17-0.67]; P=0.0014), reducing UC complication risk by nearly 70 percent. VERDICT, a Phase 4 ENTYVIO clinical trial, provides the first prospective, randomized evidence that disease clearance is an achievable and clinically rel
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum